- On stable daily doses of a statin for 45 days prior to receiving study treatment.
- Fasting LDL C equal or greater than 80 mg/dL at screening and visit approximately 1
week prior to randomization.
- History of a cardiovascular or cerebrovascular event or procedure within one year of
- Poorly controlled type 1 or type 2 diabetes mellitus (defined as HbA1c >9%).